These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Successful Treatment of a Mixed Neuroendocrine-Nonneuroendocrine Neoplasm of the Colon with Metastases to the Thyroid Gland and Liver. Kanazawa Y; Kikuchi M; Imai Y; Katakami N; Kaihara S; Shinohara S Case Rep Otolaryngol; 2020; 2020():5927610. PubMed ID: 32099708 [TBL] [Abstract][Full Text] [Related]
29. Expression of cell adhesion molecules, their ligands and tumour necrosis factor alpha in the liver of patients with metastatic gastrointestinal carcinomas. Gulubova MV Histochem J; 2002; 34(1-2):67-77. PubMed ID: 12365802 [TBL] [Abstract][Full Text] [Related]
30. The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study. Sjövall A; Järv V; Blomqvist L; Singnomklao T; Cedermark B; Glimelius B; Holm T Eur J Surg Oncol; 2004 Oct; 30(8):834-41. PubMed ID: 15336728 [TBL] [Abstract][Full Text] [Related]
31. Genomic profile of colon cancer metastases. Zeitoun G; Mourra N; Blanché-Koch H; Thomas G; Olschwang S Anticancer Res; 2008; 28(6A):3609-12. PubMed ID: 19189641 [TBL] [Abstract][Full Text] [Related]
32. Inhibition by vasoactive intestinal polypeptide (VIP) of angiogenesis induced by murine Colon 26-L5 carcinoma cells metastasized in liver. Ogasawara M; Murata J; Kamitani Y; Hayashi K; Saiki I Clin Exp Metastasis; 1999 Jun; 17(4):283-91. PubMed ID: 10545014 [TBL] [Abstract][Full Text] [Related]
33. A morphometric and immunohistochemical study on angiogenesis of human metastatic carcinomas of the liver. Terayama N; Terada T; Nakanuma Y Hepatology; 1996 Oct; 24(4):816-9. PubMed ID: 8855182 [TBL] [Abstract][Full Text] [Related]
34. Local control of the immune response in the liver. Knolle PA; Gerken G Immunol Rev; 2000 Apr; 174():21-34. PubMed ID: 10807504 [TBL] [Abstract][Full Text] [Related]
35. Oxaliplatin-induced sinusoidal obstruction syndrome mimicking metastatic colon cancer in the liver. Choi JH; Won YW; Kim HS; Oh YH; Lim S; Kim HJ Oncol Lett; 2016 Apr; 11(4):2861-2864. PubMed ID: 27073565 [TBL] [Abstract][Full Text] [Related]
36. Targeting liver sinusoidal endothelial cells with miR-20a-loaded nanoparticles reduces murine colon cancer metastasis to the liver. Marquez J; Fernandez-Piñeiro I; Araúzo-Bravo MJ; Poschmann G; Stühler K; Khatib AM; Sanchez A; Unda F; Ibarretxe G; Bernales I; Badiola I Int J Cancer; 2018 Aug; 143(3):709-719. PubMed ID: 29492958 [TBL] [Abstract][Full Text] [Related]
37. Monoclonal anti-CEA antibodies in the discrimination between primary pulmonary adenocarcinoma and colon carcinoma metastatic to the lung. Ghoneim AH; Brisson ML; Fuks A; Mobasher AA; Kreisman H Mod Pathol; 1990 Sep; 3(5):613-8. PubMed ID: 2235987 [TBL] [Abstract][Full Text] [Related]
38. The distribution of acidic coomassie blue-stained proteins from uninvolved human liver, hepatoma, normal colon, primary colon cancer, and colon metastases to the liver, determined by two-dimensional protein electrophoresis. Anderson KM; Baranowski J; Olson L; Economou SG J Surg Oncol; 1983 Nov; 24(3):184-91. PubMed ID: 6195485 [TBL] [Abstract][Full Text] [Related]
39. Genetic and molecular diversity of colon cancer hepatic metastases. Messick CA; Sanchez J; Dejulius KL; Church JM; Kalady MF Surgery; 2009 Aug; 146(2):227-31. PubMed ID: 19628078 [TBL] [Abstract][Full Text] [Related]
40. Comparative study of various biological parameters, including expression of survivin, between primary and metastatic human colonic adenocarcinomas. Agui T; McConkey DJ; Tanigawa N Anticancer Res; 2002; 22(3):1769-76. PubMed ID: 12168867 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]